International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors

Youngstein, Taryn; Hoffmann, Patrycja; Gül, Ahmet; Lane, Thirusha; Williams, Rene; Rowczenio, Dorota; Ozdogan, Huri; Ugurlu, Serdal; Ryan, John; Harty, Len; Riminton, Sean; Headley, Alex; Roesler, Joachim; Blank, Norbert; Kuemmerle-Deschner, Jasmin; Simon, Anna; Woolf, Adrian; Hawkins, Philip; Lachmann, Helen

doi:10.1093/rheumatology/kex305

International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors

Youngstein T., Hoffmann P., Gül A., Lane T., Williams R., Rowczenio D. M., ...Daha Fazla

RHEUMATOLOGY, cilt.56, sa.12, ss.2102-2108, 2017 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 56 Sayı: 12
Basım Tarihi: 2017
Doi Numarası: 10.1093/rheumatology/kex305
Dergi Adı: RHEUMATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.2102-2108
Anahtar Kelimeler: interleukin-1 inhibitors, anakinra, canakinumab, pregnancy, autoinflammatory disease, CAPS, TRAPS, biologic therapies, familial Mediterranean fever, adult onset stills disease, FAMILIAL MEDITERRANEAN FEVER, AUTOINFLAMMATORY DISEASES, REPRODUCTIVE-SYSTEM, ANAKINRA, EMBRYO
İstanbul Üniversitesi Adresli: Evet

Özet

Objective. To provide outcome data concerning pregnancies exposed to the Interleukin-1 (IL-1) inhibitors prior to conception in both men and women, during pregnancy and breast feeding.